Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Ipca Laboratories Limited

Market Cap 390B 4.14B 3.57B 3.28B 3.09B 5.8B 5.85B 38.88B 15.14B 192B 15.52B 15.19B 663B P/E 2026
35.6x
P/E 2027 * 28x
Enterprise Value 385B 4.08B 3.52B 3.24B 3.05B 5.73B 5.78B 38.38B 14.94B 189B 15.33B 15B 654B EV / Sales 2026
4.24x
EV / Sales 2027 * 3.49x
Free-Float
54.92%
Yield 2026
0.37%
Yield 2027 * 0.38%
1 day+0.44%
1 week-4.22%
Current month+2.12%
1 month-6.15%
3 months+0.19%
6 months+9.56%
Current year+8.49%
1 week 1,532.05
Extreme 1532.05
1,639.95
1 month 1,470.6
Extreme 1470.6
1,679.45
Current year 1,392
Extreme 1392
1,679.45
1 year 1,252.95
Extreme 1252.95
1,679.45
3 years 692.3
Extreme 692.3
1,757.65
5 years 670
Extreme 670
1,757.65
10 years 200
Extreme 200
1,757.65
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Change 5-day change 1-year change 3-year change Capi.($)
+0.44%-4.22% - - 4.16B
-0.94%-2.14%+40.54%+148.38% 1,001B
-0.42%-1.80%+53.69%+42.60% 566B
-0.56%-1.65%+19.27%+59.57% 393B
-1.18%+0.68%+24.66%+16.53% 326B
+1.42%+0.06%+26.36%+14.29% 277B
+1.09%+1.65%+26.61%+33.32% 276B
+1.87%+0.87%-41.49%-48.26% 193B
-1.78%+1.16%+17.79%+48.77% 188B
-1.40%+3.27%+16.16%+59.08% 158B
Average -0.15%+0.41%+20.40%+41.59% 375.2B
Weighted average by Cap. -0.38%-0.50%+29.35%+66.27%

Financials

2026 2027 *
Net sales 96.62B 1.02B 883M 812M 764M 1.44B 1.45B 9.62B 3.75B 47.42B 3.84B 3.76B 164B 108B 1.14B 985M 905M 852M 1.6B 1.61B 10.73B 4.18B 52.86B 4.28B 4.19B 183B
Net income 11.21B 119M 102M 94.19M 88.66M 167M 168M 1.12B 435M 5.5B 446M 436M 19.03B 14.04B 149M 128M 118M 111M 209M 210M 1.4B 544M 6.89B 558M 546M 23.83B
Net Debt -5.02B -53.16M -45.86M -42.16M -39.69M -74.58M -75.2M -500M -195M -2.46B -200M -195M -8.52B -14.5B -154M -133M -122M -115M -215M -217M -1.44B -562M -7.11B -577M -564M -24.61B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
16,778
Date Price Change Volume
18/06/26 1,545.00 +0.44% 922
17/06/26 1,538.25 -0.80% 6,055
16/06/26 1,550.70 -1.60% 35,980
15/06/26 1,575.90 -0.62% 47,915
12/06/26 1,585.80 -1.69% 4,010
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,538.70INR
Average target price
1,719.61INR
Spread / Average Target
+11.76%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!